Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

about

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

Item

http://www.wikidata.org/entity/Q57483931

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

@en

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

@nl

type

Item

label

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

@en

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

@nl

prefLabel

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

@en

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

@nl

P1476

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

@en

P2093

Ewelina Grywalska

http://www.w3.org/2001/XMLSchema#string

Jacek Roliński

http://www.w3.org/2001/XMLSchema#string

Marcin Pasiarski

http://www.w3.org/2001/XMLSchema#string

Stanisław Góźdź

http://www.w3.org/2001/XMLSchema#string

P2860

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Immune checkpoint‑targeted cancer immunotherapies

Molecular and cellular insights into T cell exhaustion

Overcoming T cell exhaustion in infection and cancer

The blockade of immune checkpoints in cancer immunotherapy

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

P304

6505-6524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S150817

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30323625

http://www.w3.org/2001/XMLSchema#string

P932

6177399

http://www.w3.org/2001/XMLSchema#string